[Delayed]Takara Bio Announces Transfer of SAKIGAKE and Orphan Designations for NY-ESO-1/siTCR Gene Therapy Product January 25, 2023January 25, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmail[Delayed]Takara Bio Announces Transfer of SAKIGAKE and Orphan Designations for NY-ESO-1/siTCR Gene Therapy Product | IR News | News Release ＆ IR News | Investor Relations Related News: Olympus Agree on Transfer of Evident to Bain Capital…Achieves Data Transfer Across 80 Meters…Takara Bio Group Formulated “Medium-Term Management…Takara Bio Report 2022Takara Bio Report 2023PerkinElmer to Showcase Expanded Life Science / Cell…
